wandercraft

This clearance comes just a few short months after Wandercraft received expanded CE Mark certification for enhanced clinical features.

Automatica brought a slew of product releases in June 2025. Meanwhile, humanoid robot developments continue to grab readers’ attention. 

The new funding will help propel Wandercraft into its next phase of growth, which involves deploying its new Calvin-40 humanoid.

Wandercraft, known for its exoskeletons, partnered with Renault to develop Calvin, a humanoid robot for industrial use.

The study will assess the safety and effectiveness of the Personal Exoskeleton for individuals with spinal cord injuries.

Kevin Piette works for Wandercraft, the company that built what it calls a Personal Exoskeleton that could help disabled people walk.

Atalante is a self-balanced, lower-body exoskeleton that emulates the way humans walk. The company began clinical trials for the exoskeleton in 2017. It was CE marked in 2019.

Robotic exoskeleton developer Wandercraft has raised $17.8 million in a Series B funding round, according to a ZDNet report. Funds from the round are slated to support certifications and regulatory clearances necessary to bring the exoskeleton to market, according to the report. The Paris-based company claims that its exoskeleton is the 1st to have managed…